It's another big shift to emerging markets for Big Pharma. Bayer plans to spend €1 billion on a restructuring plan that will cut 4,500 jobs--but create 2,500 new ones, largely in up-and-coming countries. The company expects to reap €800 million in annual cost savings from the plan beginning in 2013. Report